TET2 has been found mutated in patients with myeloproliferative neoplasms (MPN), MDS, AML and chronic myelomonocytic leukemia (CMML), and is the most commonly mutated gene in MDS [68-72]. Here, TET2 is linked to chronic myelomonocytic leukemia.